Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A method of pharmacoepidemiologic analysis that uses computerized Medicaid.

B B Gerstman1, F E Lundin, B V Stadel

  • 1Office of Epidemiology and Biostatistics, Food and Drug Administration, Rockville, MD 20857.

Journal of Clinical Epidemiology
|January 1, 1990
PubMed
Summary

This study introduces a pharmacoepidemiologic analysis method using Medicaid data. It enables timely risk estimation for adverse drug reactions by analyzing prescription patterns and healthcare transactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Troglitazone (Rezulin) and hepatic injury.

Pharmacoepidemiology and drug safety·2002
Same author

Blood-pressure-lowering treatment.

Lancet (London, England)·2001
Same author

Gabapentin for postherpetic neuralgia.

JAMA·1999
Same author

Black box warnings in prescription drug labeling: results of a survey of 206 drugs.

Food and drug law journal·1999
Same author

The reliability of muscle function analysis using different methods of stimulation.

JPEN. Journal of parenteral and enteral nutrition·1998
Same author

Comparison of beclomethasone, salmeterol, and placebo in children with asthma.

The New England journal of medicine·1998

Area of Science:

  • Pharmacoepidemiology
  • Health Services Research
  • Biostatistics

Background:

  • Pharmacoepidemiologic studies often rely on administrative healthcare databases.
  • Accurate assessment of drug safety and effectiveness requires robust analytical methods.
  • Computerized data, like Medicaid claims, offer large datasets for such research.

Purpose of the Study:

  • To present a novel pharmacoepidemiologic data analysis method.
  • To enable timely risk estimation of adverse drug reactions.
  • To leverage computerized Medicaid data for cohort studies.

Main Methods:

  • Utilizes a cohort design with Medicaid enrollees.
  • Defines eligibility based on a prerequisite period of Medicaid service transactions.

Related Experiment Videos

  • Establishes time-at-risk from drug dispensing to subsequent events (refill, alternative drug, or time limit).
  • Compares incidence densities of adverse events across sequential drug therapies.

    • Main Results:

    • The method allows for sequential analysis of prescription data.
    • It facilitates the identification of potential adverse drug reactions.
    • The approach aims to provide timely risk estimates for specific health outcomes.

    Conclusions:

    • The presented method offers a structured approach to pharmacoepidemiologic analysis.
    • It is particularly useful for outcomes ascertainable through computerized data.
    • The method can inform the feasibility of more detailed, customized drug safety studies.